Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #134755 on Biotech Values
hptaxis
01/10/12 3:37 PM
#134756 RE: dav1234 #134755
A year after receiving the PacBio RS single-molecule sequencer in their labs, early-access customers from two research institutions have taken their instruments through their paces and are starting to analyze "real" samples.
01/10/12 5:56 PM
#134786 RE: dav1234 #134755
Complete Genomics shipped fewer genomes than forecast in the fourth quarter of 2011, and as a result was downgraded by investment firm Oppenheimer from an 'Outperform' to a 'Perform' rating.